1
A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors
Condition(s):Locally Advanced or Metastatic Solid TumorLast Updated:January 18, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Locally Advanced or Metastatic Solid TumorLast Updated:January 18, 2024Completed
Condition(s):Breast Cancer; Breast Adenocarcinoma; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; Recurrent Breast Carcinoma; Stage IV Breast CancerLast Updated:April 4, 2022Terminated
Condition(s):Locally Advanced or Metastatic Solid TumorLast Updated:September 21, 2023Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:July 18, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.